Hospital Universitario Dr. Jose E. Gonzalez
Clinical trials sponsored by Hospital Universitario Dr. Jose E. Gonzalez, explained in plain language.
-
New Lower-Dose combo aims to tame tough lymphoma, pave way for transplant
Disease control Recruiting nowThis study is testing if a lower dose of the drug epcoritamab, when combined with standard chemotherapy drugs, can help control aggressive lymphoma that has returned or not responded to prior treatment. The goal is to shrink the cancer enough so patients can safely proceed with a…
Phase: PHASE2 • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for leukemia patients after other treatments fail
Disease control Recruiting nowThis study is testing a combination of several drugs to try to get relapsed or treatment-resistant acute lymphoblastic leukemia (ALL) back under control. The goal is to achieve a strong response so patients can then receive a potentially curative stem cell transplant. It is for a…
Phase: PHASE2 • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Weight-Loss drug could be new weapon against skin disease
Disease control Recruiting nowThis study is testing if adding the drug semaglutide, which is used for diabetes and weight loss, to standard psoriasis skin cream can better control the skin disease. It will involve 62 adults with plaque psoriasis who are also overweight or have type 2 diabetes. Researchers wil…
Phase: PHASE4 • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated Mar 11, 2026 15:06 UTC